<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

A Better Route for Diagnostics? (Drug Discovery & Development)

From the moment of its inception, the Human Genome Project was expected to yield substantial benefits in diagnostics. But the genome is only part of the story. Equally important are the mRNA transcripts that carry out the genome’s orders, the proteins they encode, and ultimately, the metabolites upon which they act. Today, thanks to rapid advances in DNA sequencing, mass spectrometry, and microarrays, among other technologies, researchers can query these biomolecules on a grand “omics” scale. (Read more at Drug Discovery & Development)

Topics: blood-based cancer test, cancer diagnostics, personalized medicine, liquid biopsy, lung cancer, mass spectrometry, molecular diagnostic, mRNA, Non-Small Cell Lung Cancer, NSCLC, oncology, biomolecules, DNA sequencing, Human Genome Project, In the News, microarrays, omics